お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
968661

低侵襲脳神経外科システムの世界市場:2020-2030年

Global Minimally Invasive Neurosurgical Systems Market: Analysis and Forecast, 2020-2030

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 210 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
低侵襲脳神経外科システムの世界市場:2020-2030年
出版日: 2020年10月26日
発行: BIS Research Inc.
ページ情報: 英文 210 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の低侵襲脳神経外科システムの市場規模は予測期間中11.8%のCAGRで推移し、2019年の4億1770万米ドルから、2030年には12億3760万米ドルの規模に成長すると予測されています。開腹手術よりも安全な選択肢への好みの変化、より正確な動きが可能な手術器具への好みの拡大、手術の価格性の向上、AI、AR、ハプティクス、遠隔手術などの分野における技術の進歩などの要因が同市場の成長を推進しています。一方で、スキルを有する専門家の不足が市場のさらなる成長の課題となっています。

当レポートでは、世界の低侵襲脳神経外科システムの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、関連法規制、特許動向、市場規模の推移・予測、製品タイプ・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 製品の定義

第2章 調査範囲

第3章 調査手法

第4章 競合情勢

  • 主な展開・戦略
  • 市場シェア分析
  • 成長シェア分析

第5章 産業分析

  • 法規制
  • COVID-19の影響
  • 待ち望まれる技術開発
  • 特許分析
  • 低侵襲手術:市場機会の分析

第6章 市場力学

  • 影響分析
  • 成長推進因子
  • 成長抑制因子
  • 市場機会

第7章 市場シナリオ

  • 世界市場の見通し
  • 主要調査結果
  • 前提因子・制約

第8章 市場分析・予測:製品タイプ別

  • 市場概要
  • 神経顕微鏡検査
  • ニューロナビゲーション
    • 光ニューロナビゲーションシステム
    • 電磁ニューロナビゲーションシステム
  • 神経内視鏡検査
    • 硬性鏡
    • 軟性鏡
  • 脳神経外科ロボティクス
    • システム(資本設備)
    • 機器・付属品
    • サービス

第9章 市場分析・予測:地域・主要国別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • オランダ
    • スイス
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • 韓国
    • インド
    • オーストラリア・ニュージーランド
    • シンガポール
    • その他
  • その他の地域(ラテンアメリカ・中東・アフリカ)

第10章 企業プロファイル

  • Corindus Vascular Robotics, Inc. (Siemens Healthineers AG)
  • Microbot Medical, Inc.
  • Synaptive Medical, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • B. Braun Melsungen AG
  • Olympus Corporation
  • Renishaw plc
  • Medtronic plc
  • Leica Microsystems (Danaher Corporation)
  • Carl Zeiss AG
  • Haag-Streit Holding AG (Metall Zug AG)
  • Karl Storz SE & Co. KG
  • Brainlab AG
  • Monteris Medical Corporation
図表

List of Tables

  • Table 1: Impact of Market Drivers
  • Table 2: Impact of Market Restraints
  • Table 5.1: Minimally Invasive Neurosurgical Systems: FDA Product Classification
  • Table 6.1: Impact Analysis: Market Drivers
  • Table 6.2: Impact Analysis: Market Restraints
  • Table 9.1: North America Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.2: U.S. Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.3: Canada Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.4: Europe Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.5: Germany Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.6: France Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.7: U.K. Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.8: Italy Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.9: Spain Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.10: Netherlands Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.11: Switzerland Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.12: Rest-of-Europe Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.13: Asia-Pacific Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.14: Japan Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.15: China Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.16: South Korea Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.17: India Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.18: Australia and New Zealand Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.19: Singapore Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.20: Rest-of-Asia Pacific Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.21: Rest-of-the-World Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030

List of Figures

  • Figure 1: Evolution of Surgery
  • Figure 2: Global Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 3: Company Share Analysis, 2019
  • Figure 4: Global Minimally Invasive Neurosurgical Systems Market (by Region), 2019 and 2030
  • Figure 5: Global Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019, 2025, and 2030
  • Figure 6: Global Minimally Invasive Neurosurgical Systems Market Growth (by Region), 2019, 2025, and 2030
  • Figure 7: Key Strategies Incorporated by the Key Players (January 2015-August 2020)
  • Figure 3.1: Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Data Triangulation
  • Figure 3.5: Bottom-Up Approach
  • Figure 4.1: Share of Key Developments and Strategies (by Category), January 2015-August 2020
  • Figure 4.2: Number of Key Developments and Strategies (by Year), January 2015-August 2020
  • Figure 4.3: Number of Key Developments and Strategies (by Regulatory and Legal Activities), January 2015-August 2020
  • Figure 4.4: Number of Key Developments and Strategies (by New Offerings), January 2015-August 2020
  • Figure 4.5: Market Share Analysis (by Company), 2019
  • Figure 4.6: Growth Share Analysis (by Product Type), 2019-2030
  • Figure 4.7: Growth Share Analysis (by Region), 2019-2030
  • Figure 5.1: Regulatory Process for Medical Devices in the U.S.
  • Figure 5.2: MDR Transitional Provisions (EU)
  • Figure 5.3: Timeline and Impact of MDR (EU)
  • Figure 5.4: Regulatory Process for Medical Devices in European Union
  • Figure 5.5: Regulatory Process for Medical Devices in the China
  • Figure 5.6: Regulatory Process for Medical Devices in Japan
  • Figure 5.7: Patent Filing Trend (by Year), January 2015-September 2020
  • Figure 5.8: Percentage of Patent Filed in Different Technological Area, (January 2015-September 2020
  • Figure 5.9: Patent Filing Trend (by Year), January 2015-September 2020
  • Figure 5.10: Minimally Invasive Surgery - Pre-COVID-19 Scenario
  • Figure 5.11: Number of Elective Surgical Procedures Cancelled due to COVID-19 (by Region)
  • Figure 6.1: Market Dynamics
  • Figure 6.2: Global Prevalence of Neurological Disorders (by Age-Group), 2013-2017
  • Figure 6.3: Global Deaths due to Neurological Disorders (by Age-Group), 2013-2017
  • Figure 6.4: Advantages of Minimally Invasive Surgical Procedures
  • Figure 6.5: Overview of Telesurgery Workflow
  • Figure 6.6: Telesurgery: Bridging the Gap Associated with Healthcare Accessibility
  • Figure 7.1: Global Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 7.2: Global Market Incremental Revenue Opportunity Analysis, 2019-2030
  • Figure 8.1: Global Minimally Invasive Neurosurgical Systems Market (by Product Type)
  • Figure 8.2: Global Minimally Invasive Neurosurgical Systems Market Share (by Product Type), 2019 and 2030
  • Figure 8.3: Global Neuromicroscopy Market, 2019-2030
  • Figure 8.4: Market Segmentation:
  • Figure 8.5: Global Neuronavigation Market, 2019-2030
  • Figure 8.6: Global Neuronavigation Market Share, 2019 and 2030
  • Figure 8.7: Global Optical Neuronavigation Systems Market, 2019-2030
  • Figure 8.8: Global Electromagnetic Neuronavigation Systems Market, 2019-2030
  • Figure 8.9: Market Potential of Endoscopy Systems (by Application)
  • Figure 8.10: Market Segmentation:
  • Figure 8.11: Global Neuroendoscopy Market, 2019-2030
  • Figure 8.12: Global Neuroendoscopy Market Share, 2019 and 2030
  • Figure 8.13: Global Rigid Neuroendoscopy Systems Market, 2019-2030
  • Figure 8.14: Global Flexible Neuroendoscopy Systems Market, 2019-2030
  • Figure 8.15: Market Segmentation:
  • Figure 8.16: Global Neurosurgical Robotics Market, 2019-2030
  • Figure 8.17: Global Neurosurgical Robotics Market Share, 2019 and 2030
  • Figure 8.18: Global Neurosurgical Robotics Market (by System), 2019-2030
  • Figure 8.19: Global Neurosurgical Robotics Market (Instruments and Accessories), 2019-2030
  • Figure 8.20: Global Neurosurgical Robotics Market (by Service), 2019-2030
  • Figure 9.1: Global Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.2: Global Minimally Invasive Neurosurgical Systems Market Share (by Region), 2019 and 2030
  • Figure 9.3: North America: Incremental Revenue Opportunity, 2019-2030
  • Figure 9.4: North America Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.5: North America Minimally Invasive Neurosurgical Systems Market Share (by Country), 2019 and 2030
  • Figure 9.6: U.S. Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.7: Canada Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.8: Europe: Incremental Revenue Opportunity, 2019-2030
  • Figure 9.9: Europe Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.10: Europe Minimally Invasive Neurosurgical Systems Market Share (by Country), 2019 and 2030
  • Figure 9.11: Germany Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.12: France Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.13: U.K. Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.14: Italy Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.15: Spain Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.16: Netherlands Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.17: Switzerland Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.18: Rest-of-Europe Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.19: Asia-Pacific: Incremental Revenue Opportunity, 2019-2030
  • Figure 9.20: Asia-Pacific Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.21: Asia-Pacific Minimally Invasive Neurosurgical Systems Market Share (by Country), 2019 and 2030
  • Figure 9.22: Japan Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.23: China Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.24: South Korea Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.25: India Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.26: Australia and New Zealand Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.27: Singapore Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.28: Rest-of-Asia-Pacific Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.29: Rest-of-the-World: Incremental Revenue Opportunity, 2019-2030
  • Figure 9.30: Rest-of-the-World Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 10.1: Global Minimally Invasive Neurosurgical Systems Market: Key Companies
  • Figure 10.2: Corindus Vascular Robotics, Inc.: Overall Financials ($Million), 2016-2018
  • Figure 10.3: Corindus Vascular Robotics, Inc.: Net Revenue (by Segment), 2016-2018
  • Figure 10.4: Corindus Vascular Robotics, Inc.: Net Revenue (by Region), 2016-2018
  • Figure 10.5: Stryker Corporation: Overall Financials ($Million), 2017-2019
  • Figure 10.6: Stryker Corporation: Net Revenue (by Segment), 2017-2019
  • Figure 10.7: Stryker Corporation: Net Revenue (by Region), 2017-2019
  • Figure 10.8: Zimmer Biomet Holdings, Inc.: Overall Financials ($Million), 2017-2019
  • Figure 10.9: Zimmer Biomet Holdings, Inc.: Net Revenue (by Product Category), 2017-2019
  • Figure 10.10: Stryker Corporation: Net Revenue (by Region), 2017-2019
  • Figure 10.11: B. Braun Melsungen AG: Overall Financials ($Million), 2017-2019
  • Figure 10.12: B. Braun Melsungen AG: Net Revenue (by Segment), 2017-2019
  • Figure 10.13: B. Braun Melsungen AG: Net Revenue (by Region), 2017-2019
  • Figure 10.14: Olympus Corporation: Overall Financials ($Million), 2018-2020
  • Figure 10.15: Olympus Corporation: Net Revenue (by Segment), 2018-2020
  • Figure 10.16: Olympus Corporation: Net Revenue (by Region), 2018-2020
  • Figure 10.17: Renishaw plc: Overall Financials ($Million), 2018-2020
  • Figure 10.18: Renishaw plc: Net Revenue (by Segment), 2018-2020
  • Figure 10.19: Renishaw plc: Net Revenue (by Region), 2018-2020
  • Figure 10.20: Medtronic plc: Overall Financials ($Million), 2018-2020
  • Figure 10.21: Medtronic plc: Net Revenue (by Segment), 2018-2020
  • Figure 10.22: Medtronic plc: Net Revenue (by Region), 2018-2020
  • Figure 10.23: Danaher Corporation: Overall Financials ($Million), 2017-2019
  • Figure 10.24: Danaher Corporation: Net Revenue (by Segment), 2017-2019
  • Figure 10.25: Danaher Corporation: Net Revenue (by Region), 2018-2019
  • Figure 10.26: Carl Zeiss AG: Overall Financials ($Million), 2017-2019
  • Figure 10.27: Carl Zeiss AG: Net Revenue (by Segment), 2017-2019
  • Figure 10.28: Carl Zeiss AG: Net Revenue (by Region), 2018-2019
  • Figure 10.29: Metall Zug AG: Overall Financials ($Million), 2017-2019
  • Figure 10.30: Metall Zug AG: Net Revenue (by Segment), 2017-2019
  • Figure 10.31: Metall Zug AG: Net Revenue (by Region), 2018-2019
目次
Product Code: BHR0856SA

"Global Minimally Invasive Neurosurgical Systems Market to Reach $1.23 Billion by 2030."

Market Report Coverage - Minimally Invasive Neurosurgical Systems

Market Segmentation

  • Neuromicroscopy
  • Neuronavigation
    • Optical Neuronavigation Systems
    • Electromagnetic Neuronavigation Systems
  • Neuroendoscopy
    • Rigid Neuroendoscopy Systems
    • Flexible Neuroendoscopy Systems
  • Neurosurgical Robotics
    • Systems
    • Instruments and Accessories
    • Services

Regional Segmentation

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Rest-of-Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia and New Zealand
    • Singapore
    • Rest-of-Asia-Pacific
  • Rest-of-the-World (Latin America and Middle East and Africa)

Growth Drivers

  • Increasing Elderly Population on the Global Level
  • Advantages of Minimally Invasive Neurosurgical Procedures Over Conventional Open Surgical Procedures
  • Availability of Technological Advanced Products in the Field of Neurosurgical Procedures

Market Challenges

  • Shortage of Skilled Professionals
  • Restrictive Reimbursement Landscape

Market Opportunities

  • Development of Long-Distance Teleoperated Surgical Robotic Systems
  • Development of Augmented Reality in the Operating Field

Key Companies Profiled

Corindus vascular Robotics Inc. (Siemens Healthineers), Microbot Medical Inc., Synaptive Medical Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., B. Braun Melsungen AG, Olympus Corporation, Renishaw Plc, Medtronic Plc, Leica Microsystems (Danaher Corporation), Carl Zeiss AG, Haag-Streit Holding AG (Metall Zug AG), Karl Storz SE & Co. KG, Brainlab AG, Monteris Medical Corporation

Key Questions Answered in this Report:

  • What is the current market size and future potential of the minimally invasive neurosurgical products?
  • What is the current market share and growth share of the different products in the market?
  • What are the guidelines implemented by different government bodies to regulate the approval of minimally invasive neurosurgical systems?
  • What are the major market drivers, restraints, and opportunities in the global minimally invasive neurosurgical systems market?
  • What is the impact of the COVID-19 pandemic on the market?
  • Which technology is being researched and worked upon to improve the neurosurgical systems?
  • Who are the leading players holding dominating shares in the global minimally invasive neurosurgical systems market?
  • What are the key development and strategies incorporated by the players of the global minimally invasive neurosurgical systems market to sustain the competition and retain their supremacy?
  • Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global minimally invasive neurosurgical systems market?

Overview on the Global Minimally Invasive Neurosurgical Systems Market

Technological advancements in neurosurgical systems and instruments have led to major breakthroughs and disruptive phases in the healthcare landscape across the world. The inventions of the digital camera further aiding in the visualization of the operating field and smaller surgical instruments, which can be passed through endoscopes, produces less trauma to a patient due to small incisions on the skull. Thus, the preference for minimally invasive neurosurgeries continued to grow over the decades, this led to the emergence of robotic-assisted surgeries because of the need for millimeter accuracy and precision, which cannot be done freehand by neurosurgeons. The idea of robotic-assisted neurosurgical procedures is being driven by the increasing need for using multiple surgical instruments through multiple access ports of the endoscopes to support minimally invasive neurosurgeries.

Global Minimally Invasive Neurosurgical Systems Market Forecast, 2020-2030

The global minimally invasive neurosurgical systems market was valued at $417.7 million in 2019 and is anticipated to reach $1,237.6 million by 2030, growing at a CAGR of 11.8% during the forecast period 2020-2030.

The evolution of technologies and methodologies has a huge impact on the global minimally invasive neurosurgical systems market. Several factors such as the shift in preference for safer options than open brain surgeries, increasing preference for surgical instruments with more dexterity, increasing affordability of the procedure, and technological advances in the field of Artificial Intelligence (AI), Augmented Reality (AR), haptics, and telesurgery are expected to play a key role in the growth of the market. The neurosurgical robot is likely to grow because of a more connected interface, motion scaling, and tremor filtration. The high installation and maintenance cost of neurosurgical robotic systems is one of the key factors restraining the growth in the adoption of surgical robotics technology. The neurosurgical systems like neuroendoscopy, neuronavigation, and neuromicroscopy will see steady growth due to the upgradation in the technologies they use. Additionally, a lack of skilled professionals will be a challenge to the growth of this market.

Competitive Landscape

The global minimally invasive neurosurgical systems market consists of large and new entrant manufacturers and vendors. Presently, with the increasing adoption of neurosurgical robotics systems and neuronavigation systems in healthcare, the manufacturers in the market have a decent number of opportunities to expand their offerings and to make a strong foothold in the market.

During January 2015- August 2020, the market witnessed approximately 12 new offerings, six partnerships, alliances and business expansions, 17 regulatory and legal approvals, four funding activities, and five mergers and acquisitions. Most of the manufacturers in the market acquires and partnerships with not only other companies but also the university and research institutions as the key strategies to develop a new version of neurosurgical systems to attain a strong financial position in the market.

The key players contributing to the global minimally invasive neurosurgical systems market are Corindus Vascular Robotics Inc. (Siemens Healthineers), Microbot Medical Inc., Synaptive Medical Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., B. Braun Melsungen AG, Olympus Corporation, Renishaw Plc, Medtronic Plc, Leica Microsystems (Danaher Corporation), Carl Zeiss AG, Haag-Streit Holding AG (Metall Zug AG), Karl Storz SE & Co. KG, Brainlab AG, Monteris Medical Corporation.

Table of Contents

1 Product Definition

2 Scope of Research Study

  • 2.1 Key Questions Answered in the Report
  • 2.2 Forecast Period Selection Criteria

3 Research Methodology

  • 3.1 Primary Research
  • 3.2 Secondary Research
  • 3.3 Data Sources and Categorization
  • 3.4 Market Estimation and Forecast Methodology
  • 3.5 Data Triangulation

4 Competitive Landscape

  • 4.1 Key Developments and Strategies
    • 4.1.1 Regulatory and Legal
    • 4.1.2 New Offerings
    • 4.1.3 Partnerships, Alliances, and Business Expansions
    • 4.1.4 Mergers and Acquisitions
    • 4.1.5 Funding Activities
  • 4.2 Market Share Analysis
    • 4.2.1 Company
    • 4.2.2 Neuromicroscopy
    • 4.2.3 Neuronavigation
    • 4.2.4 Neuroendoscopy
    • 4.2.5 Neurosurgical Robotics
  • 4.3 Growth Share Analysis
    • 4.3.1 Product Type
    • 4.3.2 Region

5 Industry Insights

  • 5.1 Legal Regulations
    • 5.1.1 U.S.
    • 5.1.2 European Union (EU)
    • 5.1.3 China
    • 5.1.4 Japan
  • 5.2 Impact of COVID-19
  • 5.3 Awaited Technological Developments
    • 5.3.1 Age of Augmented Reality (AR) Integration
  • 5.4 Patent Analysis
    • 5.4.1 Patent Filing Trends
    • 5.4.2 Patent Filing Trend (by Product Type)
    • 5.4.3 Patent Filing Trend (by Country)
    • 5.4.4 Impact of Patent Expiration
  • 5.5 Minimally Invasive Surgeries: Opportunity Analysis
    • 5.5.1 Pre-COVID-19 Scenario
    • 5.5.2 Post-COVID-19 Scenario

6 Market Dynamics

  • 6.1 Impact Analysis
  • 6.2 Market Drivers
    • 6.2.1 Increasing Elderly Population on the Global Level Propels the Demand for Minimally Invasive Neurosurgical Procedures
    • 6.2.2 Advantages of Minimally Invasive Neurosurgical Procedures Over Conventional Open Surgical Procedures
    • 6.2.3 Availability of Technological Advanced Products in the Field of Neurosurgical Procedures
  • 6.3 Market Restraints
    • 6.3.1 Lack of Skilled Professionals
    • 6.3.2 Restrictive Reimbursement Framework
  • 6.4 Market Opportunities
    • 6.4.1 Development of Long-Distance Teleoperated Surgical Robotic Systems
      • 6.4.1.1 Advantages of Long-Distance Teleoperated Surgical Robotics

7 Global Minimally Invasive Neurosurgical Systems Market Scenario

  • 7.1 Global Market Outlook, 2019-2030
  • 7.2 Key Findings
  • 7.3 Assumptions and Limitations

8 Global Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030

  • 8.1 Market Overview
  • 8.2 Neuromicroscopy
    • 8.2.1 Overview
    • 8.2.2 Market Size and Forecast
  • 8.3 Neuronavigation
    • 8.3.1 Overview
    • 8.3.2 Market Size and Forecast
    • 8.3.3 Optical Neuronavigation Systems
    • 8.3.4 Electromagnetic Neuronavigation Systems
  • 8.4 Neuroendoscopy
    • 8.4.1 Overview
    • 8.4.2 Market Size and Forecast
    • 8.4.3 Rigid Neuroendoscopy Systems
    • 8.4.4 Flexible Neuroendoscopy Systems
  • 8.5 Neurosurgical Robotics
    • 8.5.1 Overview
    • 8.5.2 Market Size and Forecast
    • 8.5.3 Systems (Capital Equipment)
    • 8.5.4 Instruments and Accessories
    • 8.5.5 Services

9 Global Minimally Invasive Neurosurgical Systems Market (by Region), 2019-2030

  • 9.1 Market Overview
  • 9.2 North America
    • 9.2.1 Opportunity Assessment
    • 9.2.2 Market Size and Forecast
    • 9.2.3 U.S.
    • 9.2.4 Canada
  • 9.3 Europe
    • 9.3.1 Opportunity Assessment
    • 9.3.2 Market Size and Forecast
    • 9.3.3 Germany
    • 9.3.4 France
    • 9.3.5 U.K.
    • 9.3.6 Italy
    • 9.3.7 Spain
    • 9.3.8 Netherlands
    • 9.3.9 Switzerland
    • 9.3.10 Rest-of-Europe
  • 9.4 Asia-Pacific
    • 9.4.1 Opportunity Assessment
    • 9.4.2 Market Size and Forecast
    • 9.4.3 Japan
    • 9.4.4 China
    • 9.4.5 South Korea
    • 9.4.6 India
    • 9.4.7 Australia and New Zealand
    • 9.4.8 Singapore
    • 9.4.9 Rest-of-Asia-Pacific
  • 9.5 Rest-of-the-World (Latin America and Middle East and Africa)
    • 9.5.1 Opportunity Assessment
    • 9.5.2 Market Size and Forecast

10 Company Profiles

  • 10.1 Overview
  • 10.2 Corindus Vascular Robotics, Inc. (Siemens Healthineers AG)
    • 10.2.1 Company Overview
    • 10.2.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.2.3 Financials
    • 10.2.4 SWOT Analysis
  • 10.3 Microbot Medical, Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.3.3 SWOT Analysis
  • 10.4 Synaptive Medical, Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.4.3 SWOT Analysis
  • 10.5 Stryker Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.5.3 Financials
    • 10.5.4 SWOT Analysis
  • 10.6 Zimmer Biomet Holdings, Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.6.3 Financials
    • 10.6.4 SWOT Analysis
  • 10.7 B. Braun Melsungen AG
    • 10.7.1 Company Overview
    • 10.7.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.7.3 Financials
    • 10.7.4 SWOT Analysis
  • 10.8 Olympus Corporation
    • 10.8.1 Company Overview
    • 10.8.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.8.3 Financials
    • 10.8.4 SWOT Analysis
  • 10.9 Renishaw plc
    • 10.9.1 Company Overview
    • 10.9.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.9.3 Financials
    • 10.9.4 SWOT Analysis
  • 10.1 Medtronic plc
    • 10.10.1 Company Overview
    • 10.10.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.10.3 Financials
    • 10.10.4 SWOT Analysis
  • 10.11 Leica Microsystems (Danaher Corporation)
    • 10.11.1 Company Overview
    • 10.11.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.11.3 Financials
    • 10.11.4 SWOT Analysis
  • 10.12 Carl Zeiss AG
    • 10.12.1 Company Overview
    • 10.12.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.12.3 Financials
    • 10.12.4 SWOT Analysis
  • 10.13 Haag-Streit Holding AG (Metall Zug AG)
    • 10.13.1 Company Overview
    • 10.13.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.13.3 Financials
    • 10.13.4 SWOT Analysis
  • 10.14 Karl Storz SE & Co. KG
    • 10.14.1 Company Overview
    • 10.14.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.14.3 SWOT Analysis
  • 10.15 Brainlab AG
    • 10.15.1 Company Overview
    • 10.15.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.15.3 SWOT Analysis
  • 10.16 Monteris Medical Corporation
    • 10.16.1 Company Overview
    • 10.16.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.16.3 SWOT Analysis
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.